Tuesday, June 30, 2009

After Genetech Deal, Roche Says ‘So Long, PhRMA; Hello, BIO’

PhRMA will feel the loss of Roche through a dip in its revenues. Membership fees are based on a company’s annual sales, and Roche is a big contributor.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)